Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiaojiao Shan

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Translational Research|July 15, 2022
XRCC2 reduced the sensitivity of NSCLC to radio-chemotherapy by arresting the cell cycleJiaojiao Shan, Xinfeng Wang, Jie Zhao
Current Drug Delivery|June 7, 2023
Improved Bioavailability and Hepatoprotective Activity of Baicalein Shuna Zhang, Ying Wang, Jiaojiao Shan, et al.
Pharmacological Reports : PR|December 3, 2014
Antiarrhythmic efficacy of CPUY102122, a multiple ion channel blocker, on rabbits with ischemia/reperfusion injuryMinhui Wang, Jiaojiao Shan, Qian Yang, et al.
Theranostics|December 2, 2025
State-of-the-art boron clusters for boron neutron-capture therapyWeiyao Wang, Enze Zhang, Jiaojiao Shan, et al.
European Journal of Medicinal Chemistry|May 15, 2014
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)Xiaoke Guo, Xianglei Ma, Qian Yang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Translational Research|July 15, 2022
XRCC2 reduced the sensitivity of NSCLC to radio-chemotherapy by arresting the cell cycleJiaojiao Shan, Xinfeng Wang, Jie Zhao
Current Drug Delivery|June 7, 2023
Improved Bioavailability and Hepatoprotective Activity of Baicalein Shuna Zhang, Ying Wang, Jiaojiao Shan, et al.
Pharmacological Reports : PR|December 3, 2014
Antiarrhythmic efficacy of CPUY102122, a multiple ion channel blocker, on rabbits with ischemia/reperfusion injuryMinhui Wang, Jiaojiao Shan, Qian Yang, et al.
Theranostics|December 2, 2025
State-of-the-art boron clusters for boron neutron-capture therapyWeiyao Wang, Enze Zhang, Jiaojiao Shan, et al.
European Journal of Medicinal Chemistry|May 15, 2014
Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I)Xiaoke Guo, Xianglei Ma, Qian Yang, et al.
Pageof 1